nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—Atenolol—Procarbazine—brain cancer	0.532	1	CrCrCtD
Propranolol—CYP2D6—Lomustine—brain cancer	0.0502	0.191	CbGbCtD
Propranolol—CYP1A2—Carmustine—brain cancer	0.0497	0.189	CbGbCtD
Propranolol—CYP2D6—Hydroxyurea—brain cancer	0.0381	0.145	CbGbCtD
Propranolol—CYP3A4—Temozolomide—brain cancer	0.0376	0.143	CbGbCtD
Propranolol—CYP3A4—Lomustine—brain cancer	0.0319	0.122	CbGbCtD
Propranolol—Raynaud's disease—Procarbazine—brain cancer	0.0209	0.17	CcSEcCtD
Propranolol—CYP3A5—Etoposide—brain cancer	0.0198	0.0754	CbGbCtD
Propranolol—Raynaud's phenomenon—Procarbazine—brain cancer	0.0175	0.142	CcSEcCtD
Propranolol—CYP1A2—Etoposide—brain cancer	0.0147	0.0561	CbGbCtD
Propranolol—ABCB1—Etoposide—brain cancer	0.0129	0.0491	CbGbCtD
Propranolol—HTR1B—dura mater—brain cancer	0.0108	0.235	CbGeAlD
Propranolol—CYP3A4—Etoposide—brain cancer	0.00772	0.0294	CbGbCtD
Propranolol—HTR1B—trigeminal nerve—brain cancer	0.00464	0.101	CbGeAlD
Propranolol—HTR1B—cranial nerve—brain cancer	0.00331	0.0719	CbGeAlD
Propranolol—Throat sore—Lomustine—brain cancer	0.00276	0.0223	CcSEcCtD
Propranolol—Oropharyngeal discomfort—Lomustine—brain cancer	0.00273	0.0221	CcSEcCtD
Propranolol—HTR1B—telencephalic ventricle—brain cancer	0.00269	0.0584	CbGeAlD
Propranolol—Oropharyngeal pain—Lomustine—brain cancer	0.00218	0.0177	CcSEcCtD
Propranolol—HTR1A—telencephalic ventricle—brain cancer	0.00217	0.0472	CbGeAlD
Propranolol—Systemic lupus erythematosus—Hydroxyurea—brain cancer	0.00176	0.0143	CcSEcCtD
Propranolol—HTR1B—ganglion—brain cancer	0.00167	0.0364	CbGeAlD
Propranolol—Disorientation—Lomustine—brain cancer	0.00161	0.0131	CcSEcCtD
Propranolol—Visual disturbance—Lomustine—brain cancer	0.00152	0.0123	CcSEcCtD
Propranolol—Lethargy—Lomustine—brain cancer	0.00147	0.0119	CcSEcCtD
Propranolol—HTR1A—ganglion—brain cancer	0.00135	0.0294	CbGeAlD
Propranolol—HTR1B—blood vessel—brain cancer	0.00133	0.0289	CbGeAlD
Propranolol—Skin ulcer—Hydroxyurea—brain cancer	0.00125	0.0102	CcSEcCtD
Propranolol—Nightmare—Procarbazine—brain cancer	0.00122	0.00987	CcSEcCtD
Propranolol—Myopathy—Temozolomide—brain cancer	0.00109	0.00881	CcSEcCtD
Propranolol—HTR1A—hindbrain—brain cancer	0.00102	0.0223	CbGeAlD
Propranolol—Disorientation—Procarbazine—brain cancer	0.00102	0.00829	CcSEcCtD
Propranolol—Vascular purpura—Procarbazine—brain cancer	0.00102	0.00829	CcSEcCtD
Propranolol—Visual impairment—Lomustine—brain cancer	0.000961	0.00779	CcSEcCtD
Propranolol—Purpura—Procarbazine—brain cancer	0.00095	0.0077	CcSEcCtD
Propranolol—Lethargy—Procarbazine—brain cancer	0.000934	0.00757	CcSEcCtD
Propranolol—Alopecia—Lomustine—brain cancer	0.000881	0.00714	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.000824	0.00668	CcSEcCtD
Propranolol—Terbinafine—CYP2C9—brain cancer	0.000819	0.373	CrCbGaD
Propranolol—Laryngospasm—Etoposide—brain cancer	0.000817	0.00662	CcSEcCtD
Propranolol—Infection—Carboplatin—brain cancer	0.000805	0.00652	CcSEcCtD
Propranolol—Disorientation—Hydroxyurea—brain cancer	0.000792	0.00642	CcSEcCtD
Propranolol—HTR1B—brainstem—brain cancer	0.000727	0.0158	CbGeAlD
Propranolol—Dry eye—Temozolomide—brain cancer	0.000704	0.00571	CcSEcCtD
Propranolol—Infection—Lomustine—brain cancer	0.000704	0.00571	CcSEcCtD
Propranolol—Pain—Carboplatin—brain cancer	0.000693	0.00561	CcSEcCtD
Propranolol—CYP3A7—endocrine gland—brain cancer	0.000686	0.0149	CbGeAlD
Propranolol—HTR1B—telencephalon—brain cancer	0.000646	0.014	CbGeAlD
Propranolol—Body temperature increased—Carboplatin—brain cancer	0.00064	0.00519	CcSEcCtD
Propranolol—Hallucination—Procarbazine—brain cancer	0.00063	0.00511	CcSEcCtD
Propranolol—Vascular purpura—Temozolomide—brain cancer	0.000619	0.00501	CcSEcCtD
Propranolol—Decreased appetite—Lomustine—brain cancer	0.000616	0.00499	CcSEcCtD
Propranolol—Amnesia—Carmustine—brain cancer	0.00061	0.00494	CcSEcCtD
Propranolol—ADRB1—telencephalon—brain cancer	0.000607	0.0132	CbGeAlD
Propranolol—Amnesia—Temozolomide—brain cancer	0.000589	0.00477	CcSEcCtD
Propranolol—HTR1A—brainstem—brain cancer	0.000587	0.0128	CbGeAlD
Propranolol—Dermatitis exfoliative—Temozolomide—brain cancer	0.000587	0.00475	CcSEcCtD
Propranolol—Purpura—Temozolomide—brain cancer	0.000574	0.00465	CcSEcCtD
Propranolol—Neutropenia—Hydroxyurea—brain cancer	0.000573	0.00464	CcSEcCtD
Propranolol—Body temperature increased—Lomustine—brain cancer	0.00056	0.00454	CcSEcCtD
Propranolol—Alopecia—Procarbazine—brain cancer	0.00056	0.00454	CcSEcCtD
Propranolol—CYP2D6—hindbrain—brain cancer	0.000556	0.0121	CbGeAlD
Propranolol—Infestation NOS—Hydroxyurea—brain cancer	0.000546	0.00443	CcSEcCtD
Propranolol—Infestation—Hydroxyurea—brain cancer	0.000546	0.00443	CcSEcCtD
Propranolol—Affect lability—Temozolomide—brain cancer	0.000545	0.00442	CcSEcCtD
Propranolol—Carvedilol—VEGFA—brain cancer	0.000525	0.239	CrCbGaD
Propranolol—Mood swings—Temozolomide—brain cancer	0.000524	0.00425	CcSEcCtD
Propranolol—HTR1A—telencephalon—brain cancer	0.000521	0.0113	CbGeAlD
Propranolol—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000498	0.00404	CcSEcCtD
Propranolol—Cardiac failure congestive—Etoposide—brain cancer	0.000488	0.00396	CcSEcCtD
Propranolol—Hallucination—Hydroxyurea—brain cancer	0.000488	0.00395	CcSEcCtD
Propranolol—ORM1—spinal cord—brain cancer	0.000482	0.0105	CbGeAlD
Propranolol—Cough—Procarbazine—brain cancer	0.000481	0.0039	CcSEcCtD
Propranolol—Convulsion—Procarbazine—brain cancer	0.000478	0.00387	CcSEcCtD
Propranolol—HTR1B—midbrain—brain cancer	0.000464	0.0101	CbGeAlD
Propranolol—Neutropenia—Carmustine—brain cancer	0.000463	0.00375	CcSEcCtD
Propranolol—Bronchitis—Temozolomide—brain cancer	0.00046	0.00373	CcSEcCtD
Propranolol—Anaphylactoid reaction—Etoposide—brain cancer	0.000458	0.00371	CcSEcCtD
Propranolol—HTR1B—spinal cord—brain cancer	0.000452	0.00983	CbGeAlD
Propranolol—Vomiting—Lomustine—brain cancer	0.000451	0.00365	CcSEcCtD
Propranolol—Propafenone—CYP2C9—brain cancer	0.000449	0.204	CrCbGaD
Propranolol—Neutropenia—Temozolomide—brain cancer	0.000447	0.00363	CcSEcCtD
Propranolol—Infection—Procarbazine—brain cancer	0.000447	0.00362	CcSEcCtD
Propranolol—Erectile dysfunction—Temozolomide—brain cancer	0.000441	0.00357	CcSEcCtD
Propranolol—Depression—Carmustine—brain cancer	0.00044	0.00357	CcSEcCtD
Propranolol—ORM1—endocrine gland—brain cancer	0.000434	0.00944	CbGeAlD
Propranolol—Alopecia—Hydroxyurea—brain cancer	0.000433	0.00351	CcSEcCtD
Propranolol—Erythema—Hydroxyurea—brain cancer	0.000427	0.00346	CcSEcCtD
Propranolol—Infestation NOS—Temozolomide—brain cancer	0.000427	0.00346	CcSEcCtD
Propranolol—Infestation—Temozolomide—brain cancer	0.000427	0.00346	CcSEcCtD
Propranolol—Depression—Temozolomide—brain cancer	0.000425	0.00345	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000423	0.00343	CcSEcCtD
Propranolol—Cardiac arrest—Etoposide—brain cancer	0.000421	0.00341	CcSEcCtD
Propranolol—Nausea—Lomustine—brain cancer	0.000421	0.00341	CcSEcCtD
Propranolol—ABCB1—blood vessel—brain cancer	0.000419	0.00912	CbGeAlD
Propranolol—HTR1B—endocrine gland—brain cancer	0.000407	0.00885	CbGeAlD
Propranolol—Insomnia—Procarbazine—brain cancer	0.000407	0.0033	CcSEcCtD
Propranolol—Carvedilol—CYP2C9—brain cancer	0.000404	0.184	CrCbGaD
Propranolol—Paraesthesia—Procarbazine—brain cancer	0.000404	0.00327	CcSEcCtD
Propranolol—HTR1B—head—brain cancer	0.000402	0.00874	CbGeAlD
Propranolol—Somnolence—Procarbazine—brain cancer	0.0004	0.00324	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000399	0.00323	CcSEcCtD
Propranolol—Hallucination—Carmustine—brain cancer	0.000394	0.0032	CcSEcCtD
Propranolol—ORM1—central nervous system—brain cancer	0.000391	0.00851	CbGeAlD
Propranolol—Decreased appetite—Procarbazine—brain cancer	0.000391	0.00317	CcSEcCtD
Propranolol—Fatigue—Procarbazine—brain cancer	0.000388	0.00314	CcSEcCtD
Propranolol—Pain—Procarbazine—brain cancer	0.000385	0.00312	CcSEcCtD
Propranolol—Constipation—Procarbazine—brain cancer	0.000385	0.00312	CcSEcCtD
Propranolol—ADRB1—endocrine gland—brain cancer	0.000383	0.00833	CbGeAlD
Propranolol—Visual impairment—Carmustine—brain cancer	0.000382	0.00309	CcSEcCtD
Propranolol—Hallucination—Temozolomide—brain cancer	0.000381	0.00309	CcSEcCtD
Propranolol—Pharyngitis—Temozolomide—brain cancer	0.00038	0.00308	CcSEcCtD
Propranolol—ADRB1—head—brain cancer	0.000378	0.00822	CbGeAlD
Propranolol—Bronchospasm—Etoposide—brain cancer	0.000377	0.00305	CcSEcCtD
Propranolol—HTR1A—midbrain—brain cancer	0.000374	0.00813	CbGeAlD
Propranolol—Convulsion—Hydroxyurea—brain cancer	0.00037	0.003	CcSEcCtD
Propranolol—Visual impairment—Temozolomide—brain cancer	0.000369	0.00299	CcSEcCtD
Propranolol—Gastrointestinal pain—Procarbazine—brain cancer	0.000368	0.00298	CcSEcCtD
Propranolol—HTR1B—central nervous system—brain cancer	0.000367	0.00798	CbGeAlD
Propranolol—HTR1A—spinal cord—brain cancer	0.000365	0.00793	CbGeAlD
Propranolol—Erythema multiforme—Temozolomide—brain cancer	0.000362	0.00293	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000361	0.00292	CcSEcCtD
Propranolol—Neutropenia—Etoposide—brain cancer	0.000358	0.0029	CcSEcCtD
Propranolol—Urticaria—Procarbazine—brain cancer	0.000357	0.0029	CcSEcCtD
Propranolol—Body temperature increased—Procarbazine—brain cancer	0.000356	0.00288	CcSEcCtD
Propranolol—Abdominal pain—Procarbazine—brain cancer	0.000356	0.00288	CcSEcCtD
Propranolol—Cardiac disorder—Temozolomide—brain cancer	0.000355	0.00288	CcSEcCtD
Propranolol—Alopecia—Carmustine—brain cancer	0.00035	0.00284	CcSEcCtD
Propranolol—Mental disorder—Carmustine—brain cancer	0.000347	0.00281	CcSEcCtD
Propranolol—Infection—Hydroxyurea—brain cancer	0.000346	0.0028	CcSEcCtD
Propranolol—ADRB1—central nervous system—brain cancer	0.000345	0.0075	CbGeAlD
Propranolol—Erythema—Carmustine—brain cancer	0.000345	0.0028	CcSEcCtD
Propranolol—Nervous system disorder—Hydroxyurea—brain cancer	0.000341	0.00277	CcSEcCtD
Propranolol—Infestation NOS—Etoposide—brain cancer	0.000341	0.00277	CcSEcCtD
Propranolol—Infestation—Etoposide—brain cancer	0.000341	0.00277	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000338	0.00274	CcSEcCtD
Propranolol—Alopecia—Temozolomide—brain cancer	0.000338	0.00274	CcSEcCtD
Propranolol—Skin disorder—Hydroxyurea—brain cancer	0.000338	0.00274	CcSEcCtD
Propranolol—Mental disorder—Temozolomide—brain cancer	0.000335	0.00272	CcSEcCtD
Propranolol—Erythema—Temozolomide—brain cancer	0.000333	0.0027	CcSEcCtD
Propranolol—Hypersensitivity—Procarbazine—brain cancer	0.000331	0.00269	CcSEcCtD
Propranolol—HTR1A—endocrine gland—brain cancer	0.000329	0.00714	CbGeAlD
Propranolol—HTR1A—head—brain cancer	0.000324	0.00705	CbGeAlD
Propranolol—Asthenia—Procarbazine—brain cancer	0.000323	0.00262	CcSEcCtD
Propranolol—CYP2D6—brainstem—brain cancer	0.000319	0.00693	CbGeAlD
Propranolol—Agranulocytosis—Etoposide—brain cancer	0.000319	0.00258	CcSEcCtD
Propranolol—Agitation—Carmustine—brain cancer	0.000317	0.00257	CcSEcCtD
Propranolol—Dyspnoea—Hydroxyurea—brain cancer	0.00031	0.00252	CcSEcCtD
Propranolol—Somnolence—Hydroxyurea—brain cancer	0.00031	0.00251	CcSEcCtD
Propranolol—Diarrhoea—Procarbazine—brain cancer	0.000308	0.0025	CcSEcCtD
Propranolol—CYP2C19—endocrine gland—brain cancer	0.000307	0.00667	CbGeAlD
Propranolol—Dyspepsia—Hydroxyurea—brain cancer	0.000307	0.00248	CcSEcCtD
Propranolol—Agitation—Temozolomide—brain cancer	0.000306	0.00248	CcSEcCtD
Propranolol—Decreased appetite—Hydroxyurea—brain cancer	0.000303	0.00245	CcSEcCtD
Propranolol—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000301	0.00244	CcSEcCtD
Propranolol—Fatigue—Hydroxyurea—brain cancer	0.0003	0.00243	CcSEcCtD
Propranolol—Vertigo—Temozolomide—brain cancer	0.000299	0.00243	CcSEcCtD
Propranolol—Convulsion—Carmustine—brain cancer	0.000299	0.00242	CcSEcCtD
Propranolol—Pain—Hydroxyurea—brain cancer	0.000298	0.00241	CcSEcCtD
Propranolol—Constipation—Hydroxyurea—brain cancer	0.000298	0.00241	CcSEcCtD
Propranolol—Dizziness—Procarbazine—brain cancer	0.000298	0.00241	CcSEcCtD
Propranolol—HTR1A—central nervous system—brain cancer	0.000296	0.00644	CbGeAlD
Propranolol—HTR1B—brain—brain cancer	0.000291	0.00633	CbGeAlD
Propranolol—Cough—Temozolomide—brain cancer	0.000291	0.00236	CcSEcCtD
Propranolol—Erythema multiforme—Etoposide—brain cancer	0.00029	0.00235	CcSEcCtD
Propranolol—HTR1A—cerebellum—brain cancer	0.000289	0.00629	CbGeAlD
Propranolol—Convulsion—Temozolomide—brain cancer	0.000289	0.00234	CcSEcCtD
Propranolol—Vomiting—Procarbazine—brain cancer	0.000286	0.00232	CcSEcCtD
Propranolol—Cardiac disorder—Etoposide—brain cancer	0.000284	0.0023	CcSEcCtD
Propranolol—Rash—Procarbazine—brain cancer	0.000284	0.0023	CcSEcCtD
Propranolol—Dermatitis—Procarbazine—brain cancer	0.000283	0.0023	CcSEcCtD
Propranolol—CYP2D6—telencephalon—brain cancer	0.000283	0.00615	CbGeAlD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000282	0.00228	CcSEcCtD
Propranolol—Infection—Carmustine—brain cancer	0.00028	0.00227	CcSEcCtD
Propranolol—Body temperature increased—Hydroxyurea—brain cancer	0.000275	0.00223	CcSEcCtD
Propranolol—ADRB1—brain—brain cancer	0.000274	0.00596	CbGeAlD
Propranolol—Anaphylactic shock—Temozolomide—brain cancer	0.000272	0.0022	CcSEcCtD
Propranolol—Alopecia—Etoposide—brain cancer	0.000271	0.00219	CcSEcCtD
Propranolol—Infection—Temozolomide—brain cancer	0.00027	0.00219	CcSEcCtD
Propranolol—Nausea—Procarbazine—brain cancer	0.000267	0.00217	CcSEcCtD
Propranolol—Nervous system disorder—Temozolomide—brain cancer	0.000267	0.00216	CcSEcCtD
Propranolol—Skin disorder—Temozolomide—brain cancer	0.000264	0.00214	CcSEcCtD
Propranolol—Hypersensitivity—Hydroxyurea—brain cancer	0.000257	0.00208	CcSEcCtD
Propranolol—Insomnia—Carmustine—brain cancer	0.000255	0.00206	CcSEcCtD
Propranolol—Paraesthesia—Carmustine—brain cancer	0.000253	0.00205	CcSEcCtD
Propranolol—Dyspnoea—Carmustine—brain cancer	0.000251	0.00203	CcSEcCtD
Propranolol—CYP1A2—endocrine gland—brain cancer	0.00025	0.00544	CbGeAlD
Propranolol—Somnolence—Carmustine—brain cancer	0.00025	0.00203	CcSEcCtD
Propranolol—Asthenia—Hydroxyurea—brain cancer	0.00025	0.00203	CcSEcCtD
Propranolol—CYP1A1—endocrine gland—brain cancer	0.000247	0.00537	CbGeAlD
Propranolol—Insomnia—Temozolomide—brain cancer	0.000246	0.00199	CcSEcCtD
Propranolol—Decreased appetite—Carmustine—brain cancer	0.000245	0.00198	CcSEcCtD
Propranolol—Paraesthesia—Temozolomide—brain cancer	0.000244	0.00198	CcSEcCtD
Propranolol—CYP1A1—head—brain cancer	0.000244	0.0053	CbGeAlD
Propranolol—Gastrointestinal disorder—Carmustine—brain cancer	0.000243	0.00197	CcSEcCtD
Propranolol—Dyspnoea—Temozolomide—brain cancer	0.000243	0.00197	CcSEcCtD
Propranolol—Somnolence—Temozolomide—brain cancer	0.000242	0.00196	CcSEcCtD
Propranolol—CYP3A5—endocrine gland—brain cancer	0.000242	0.00525	CbGeAlD
Propranolol—Constipation—Carmustine—brain cancer	0.000241	0.00195	CcSEcCtD
Propranolol—Pain—Carmustine—brain cancer	0.000241	0.00195	CcSEcCtD
Propranolol—Vertigo—Etoposide—brain cancer	0.00024	0.00194	CcSEcCtD
Propranolol—Dyspepsia—Temozolomide—brain cancer	0.000239	0.00194	CcSEcCtD
Propranolol—Diarrhoea—Hydroxyurea—brain cancer	0.000238	0.00193	CcSEcCtD
Propranolol—Decreased appetite—Temozolomide—brain cancer	0.000236	0.00192	CcSEcCtD
Propranolol—HTR1A—brain—brain cancer	0.000235	0.00511	CbGeAlD
Propranolol—Gastrointestinal disorder—Temozolomide—brain cancer	0.000235	0.0019	CcSEcCtD
Propranolol—Fatigue—Temozolomide—brain cancer	0.000235	0.0019	CcSEcCtD
Propranolol—Cough—Etoposide—brain cancer	0.000233	0.00189	CcSEcCtD
Propranolol—Pain—Temozolomide—brain cancer	0.000233	0.00189	CcSEcCtD
Propranolol—Constipation—Temozolomide—brain cancer	0.000233	0.00189	CcSEcCtD
Propranolol—Convulsion—Etoposide—brain cancer	0.000231	0.00187	CcSEcCtD
Propranolol—Dizziness—Hydroxyurea—brain cancer	0.00023	0.00187	CcSEcCtD
Propranolol—Gastrointestinal pain—Carmustine—brain cancer	0.00023	0.00187	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000226	0.00183	CcSEcCtD
Propranolol—CYP1A1—central nervous system—brain cancer	0.000223	0.00484	CbGeAlD
Propranolol—Body temperature increased—Carmustine—brain cancer	0.000223	0.0018	CcSEcCtD
Propranolol—Abdominal pain—Carmustine—brain cancer	0.000223	0.0018	CcSEcCtD
Propranolol—Gastrointestinal pain—Temozolomide—brain cancer	0.000222	0.0018	CcSEcCtD
Propranolol—Vomiting—Hydroxyurea—brain cancer	0.000221	0.00179	CcSEcCtD
Propranolol—Rash—Hydroxyurea—brain cancer	0.00022	0.00178	CcSEcCtD
Propranolol—Dermatitis—Hydroxyurea—brain cancer	0.000219	0.00178	CcSEcCtD
Propranolol—Anaphylactic shock—Etoposide—brain cancer	0.000218	0.00176	CcSEcCtD
Propranolol—Infection—Etoposide—brain cancer	0.000216	0.00175	CcSEcCtD
Propranolol—Urticaria—Temozolomide—brain cancer	0.000216	0.00175	CcSEcCtD
Propranolol—Abdominal pain—Temozolomide—brain cancer	0.000215	0.00174	CcSEcCtD
Propranolol—Body temperature increased—Temozolomide—brain cancer	0.000215	0.00174	CcSEcCtD
Propranolol—Skin disorder—Etoposide—brain cancer	0.000211	0.00171	CcSEcCtD
Propranolol—Hypersensitivity—Carmustine—brain cancer	0.000207	0.00168	CcSEcCtD
Propranolol—Nausea—Hydroxyurea—brain cancer	0.000207	0.00168	CcSEcCtD
Propranolol—ABCB1—telencephalon—brain cancer	0.000203	0.00442	CbGeAlD
Propranolol—Asthenia—Carmustine—brain cancer	0.000202	0.00164	CcSEcCtD
Propranolol—Hypersensitivity—Temozolomide—brain cancer	0.0002	0.00162	CcSEcCtD
Propranolol—Paraesthesia—Etoposide—brain cancer	0.000195	0.00158	CcSEcCtD
Propranolol—Asthenia—Temozolomide—brain cancer	0.000195	0.00158	CcSEcCtD
Propranolol—Dyspnoea—Etoposide—brain cancer	0.000194	0.00157	CcSEcCtD
Propranolol—Somnolence—Etoposide—brain cancer	0.000194	0.00157	CcSEcCtD
Propranolol—Diarrhoea—Carmustine—brain cancer	0.000193	0.00156	CcSEcCtD
Propranolol—Decreased appetite—Etoposide—brain cancer	0.000189	0.00153	CcSEcCtD
Propranolol—Gastrointestinal disorder—Etoposide—brain cancer	0.000188	0.00152	CcSEcCtD
Propranolol—Fatigue—Etoposide—brain cancer	0.000188	0.00152	CcSEcCtD
Propranolol—Dizziness—Carmustine—brain cancer	0.000186	0.00151	CcSEcCtD
Propranolol—Pain—Etoposide—brain cancer	0.000186	0.00151	CcSEcCtD
Propranolol—Constipation—Etoposide—brain cancer	0.000186	0.00151	CcSEcCtD
Propranolol—Diarrhoea—Temozolomide—brain cancer	0.000186	0.00151	CcSEcCtD
Propranolol—CYP3A4—endocrine gland—brain cancer	0.000181	0.00394	CbGeAlD
Propranolol—Dizziness—Temozolomide—brain cancer	0.00018	0.00146	CcSEcCtD
Propranolol—Vomiting—Carmustine—brain cancer	0.000179	0.00145	CcSEcCtD
Propranolol—CYP2D6—endocrine gland—brain cancer	0.000178	0.00388	CbGeAlD
Propranolol—Gastrointestinal pain—Etoposide—brain cancer	0.000178	0.00144	CcSEcCtD
Propranolol—Rash—Carmustine—brain cancer	0.000177	0.00144	CcSEcCtD
Propranolol—Dermatitis—Carmustine—brain cancer	0.000177	0.00144	CcSEcCtD
Propranolol—CYP1A1—brain—brain cancer	0.000177	0.00384	CbGeAlD
Propranolol—CYP2D6—head—brain cancer	0.000176	0.00383	CbGeAlD
Propranolol—Vomiting—Temozolomide—brain cancer	0.000173	0.0014	CcSEcCtD
Propranolol—Urticaria—Etoposide—brain cancer	0.000173	0.0014	CcSEcCtD
Propranolol—Body temperature increased—Etoposide—brain cancer	0.000172	0.00139	CcSEcCtD
Propranolol—Abdominal pain—Etoposide—brain cancer	0.000172	0.00139	CcSEcCtD
Propranolol—Rash—Temozolomide—brain cancer	0.000172	0.00139	CcSEcCtD
Propranolol—Dermatitis—Temozolomide—brain cancer	0.000171	0.00139	CcSEcCtD
Propranolol—ABCB1—gonad—brain cancer	0.00017	0.00369	CbGeAlD
Propranolol—Nausea—Carmustine—brain cancer	0.000167	0.00136	CcSEcCtD
Propranolol—ABCB1—pituitary gland—brain cancer	0.000166	0.0036	CbGeAlD
Propranolol—CYP3A4—central nervous system—brain cancer	0.000163	0.00355	CbGeAlD
Propranolol—Nausea—Temozolomide—brain cancer	0.000162	0.00131	CcSEcCtD
Propranolol—CYP2D6—central nervous system—brain cancer	0.000161	0.00349	CbGeAlD
Propranolol—Hypersensitivity—Etoposide—brain cancer	0.00016	0.0013	CcSEcCtD
Propranolol—ABCB1—medulla oblongata—brain cancer	0.00016	0.00347	CbGeAlD
Propranolol—CYP2D6—cerebellum—brain cancer	0.000157	0.00342	CbGeAlD
Propranolol—Asthenia—Etoposide—brain cancer	0.000156	0.00127	CcSEcCtD
Propranolol—Diarrhoea—Etoposide—brain cancer	0.000149	0.00121	CcSEcCtD
Propranolol—ABCB1—midbrain—brain cancer	0.000146	0.00318	CbGeAlD
Propranolol—Dizziness—Etoposide—brain cancer	0.000144	0.00117	CcSEcCtD
Propranolol—ABCB1—spinal cord—brain cancer	0.000143	0.0031	CbGeAlD
Propranolol—Vomiting—Etoposide—brain cancer	0.000138	0.00112	CcSEcCtD
Propranolol—Rash—Etoposide—brain cancer	0.000137	0.00111	CcSEcCtD
Propranolol—Dermatitis—Etoposide—brain cancer	0.000137	0.00111	CcSEcCtD
Propranolol—Nausea—Etoposide—brain cancer	0.000129	0.00105	CcSEcCtD
Propranolol—ABCB1—endocrine gland—brain cancer	0.000128	0.00279	CbGeAlD
Propranolol—CYP2D6—brain—brain cancer	0.000128	0.00277	CbGeAlD
Propranolol—ABCB1—head—brain cancer	0.000127	0.00275	CbGeAlD
Propranolol—ABCB1—central nervous system—brain cancer	0.000116	0.00251	CbGeAlD
Propranolol—ABCB1—cerebellum—brain cancer	0.000113	0.00246	CbGeAlD
Propranolol—ABCB1—brain—brain cancer	9.18e-05	0.002	CbGeAlD
Propranolol—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.54e-05	0.000748	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PTCH2—brain cancer	2.54e-05	0.000747	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—GLI2—brain cancer	2.53e-05	0.000743	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HES5—brain cancer	2.52e-05	0.00074	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—STRADA—brain cancer	2.5e-05	0.000734	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.48e-05	0.000728	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HES5—brain cancer	2.46e-05	0.000723	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—TRPC6—brain cancer	2.46e-05	0.000723	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—STRADA—brain cancer	2.44e-05	0.000718	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—TRPC6—brain cancer	2.41e-05	0.000707	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—STRADA—brain cancer	2.39e-05	0.000702	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—GLI1—brain cancer	2.38e-05	0.000699	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—TRPC6—brain cancer	2.35e-05	0.000692	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—SHH—brain cancer	2.32e-05	0.000681	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—VAV1—brain cancer	2.31e-05	0.00068	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—SHH—brain cancer	2.3e-05	0.000678	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—BSG—brain cancer	2.29e-05	0.000675	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—BSG—brain cancer	2.29e-05	0.000674	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—SHH—brain cancer	2.27e-05	0.000666	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—SUFU—brain cancer	2.25e-05	0.000662	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—TRPC6—brain cancer	2.23e-05	0.000657	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.23e-05	0.000655	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TRPC6—brain cancer	2.22e-05	0.000654	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—SHH—brain cancer	2.21e-05	0.000651	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—PTCH1—brain cancer	2.2e-05	0.000646	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—SMO—brain cancer	2.2e-05	0.000646	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PTCH1—brain cancer	2.18e-05	0.000643	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—SMO—brain cancer	2.18e-05	0.000643	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—TRPC6—brain cancer	2.18e-05	0.000642	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—GFAP—brain cancer	2.17e-05	0.000639	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—PTCH1—brain cancer	2.15e-05	0.000632	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—SMO—brain cancer	2.15e-05	0.000632	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—TRPC6—brain cancer	2.14e-05	0.000628	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—VAV1—brain cancer	2.1e-05	0.000618	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—SMO—brain cancer	2.1e-05	0.000618	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—PTCH1—brain cancer	2.1e-05	0.000618	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.1e-05	0.000617	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ABR—brain cancer	2.08e-05	0.000613	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—HEY1—brain cancer	2.06e-05	0.000606	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ABR—brain cancer	2.04e-05	0.000599	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—DLL1—brain cancer	2.02e-05	0.000594	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—GLI2—brain cancer	2.01e-05	0.000592	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ABR—brain cancer	1.99e-05	0.000586	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—IDH1—brain cancer	1.97e-05	0.00058	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—PIK3CG—brain cancer	1.97e-05	0.00058	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—IDH1—brain cancer	1.97e-05	0.000579	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—GLI2—brain cancer	1.97e-05	0.000579	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CYP2C9—brain cancer	1.95e-05	0.000573	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.93e-05	0.000567	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—GLI2—brain cancer	1.92e-05	0.000566	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—GLI1—brain cancer	1.89e-05	0.000556	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—GLI1—brain cancer	1.85e-05	0.000544	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—VAV1—brain cancer	1.84e-05	0.000542	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CYP2C9—brain cancer	1.84e-05	0.000542	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—GLI1—brain cancer	1.81e-05	0.000532	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—VAV1—brain cancer	1.8e-05	0.00053	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SUFU—brain cancer	1.79e-05	0.000527	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—PIK3CG—brain cancer	1.79e-05	0.000526	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—VAV1—brain cancer	1.76e-05	0.000518	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SUFU—brain cancer	1.75e-05	0.000516	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.75e-05	0.000515	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—NOTCH2—brain cancer	1.75e-05	0.000514	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—GFAP—brain cancer	1.73e-05	0.000509	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—SHH—brain cancer	1.72e-05	0.000505	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SUFU—brain cancer	1.72e-05	0.000505	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—GFAP—brain cancer	1.69e-05	0.000498	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—VAV1—brain cancer	1.67e-05	0.000492	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—VAV1—brain cancer	1.67e-05	0.00049	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—BSG—brain cancer	1.66e-05	0.000488	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TRPC6—brain cancer	1.66e-05	0.000487	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—GFAP—brain cancer	1.66e-05	0.000487	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HEY1—brain cancer	1.64e-05	0.000482	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—VAV1—brain cancer	1.64e-05	0.000481	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.63e-05	0.000479	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PTCH1—brain cancer	1.63e-05	0.000479	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—SMO—brain cancer	1.63e-05	0.000479	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—DLL1—brain cancer	1.61e-05	0.000473	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HEY1—brain cancer	1.6e-05	0.000472	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—VAV1—brain cancer	1.6e-05	0.000471	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—DLL1—brain cancer	1.57e-05	0.000463	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HEY1—brain cancer	1.57e-05	0.000461	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—BSG—brain cancer	1.57e-05	0.000461	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—ENO2—brain cancer	1.56e-05	0.000459	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—ENO2—brain cancer	1.56e-05	0.000458	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—DLL1—brain cancer	1.54e-05	0.000453	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CYP2C9—brain cancer	1.51e-05	0.000443	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CYP2C9—brain cancer	1.47e-05	0.000433	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—PIK3CG—brain cancer	1.47e-05	0.000432	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.44e-05	0.000423	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—HES1—brain cancer	1.43e-05	0.000421	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—IDH1—brain cancer	1.43e-05	0.000419	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.43e-05	0.000419	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—IL2—brain cancer	1.39e-05	0.000408	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CYP2C9—brain cancer	1.39e-05	0.000408	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SHH—brain cancer	1.37e-05	0.000402	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PDGFRA—brain cancer	1.36e-05	0.000401	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—IDH1—brain cancer	1.35e-05	0.000396	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SHH—brain cancer	1.34e-05	0.000394	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—PIK3CG—brain cancer	1.33e-05	0.000392	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—SPP1—brain cancer	1.32e-05	0.000389	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TRPC6—brain cancer	1.32e-05	0.000388	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SHH—brain cancer	1.31e-05	0.000385	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—NOTCH2—brain cancer	1.3e-05	0.000383	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PTCH1—brain cancer	1.3e-05	0.000381	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SMO—brain cancer	1.3e-05	0.000381	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TRPC6—brain cancer	1.29e-05	0.000379	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—BSG—brain cancer	1.28e-05	0.000377	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PTCH1—brain cancer	1.27e-05	0.000373	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SMO—brain cancer	1.27e-05	0.000373	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TRPC6—brain cancer	1.26e-05	0.000371	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—IL2—brain cancer	1.26e-05	0.00037	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.25e-05	0.000369	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—BSG—brain cancer	1.25e-05	0.000368	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—VAV1—brain cancer	1.24e-05	0.000365	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SMO—brain cancer	1.24e-05	0.000365	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PTCH1—brain cancer	1.24e-05	0.000365	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IRS2—brain cancer	1.2e-05	0.000352	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—BSG—brain cancer	1.18e-05	0.000347	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP2C9—brain cancer	1.17e-05	0.000345	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—PIK3CG—brain cancer	1.17e-05	0.000344	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.15e-05	0.000339	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—PIK3CG—brain cancer	1.14e-05	0.000337	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.13e-05	0.000332	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ENO2—brain cancer	1.13e-05	0.000331	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—PIK3CG—brain cancer	1.12e-05	0.000329	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—IDH1—brain cancer	1.1e-05	0.000324	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.1e-05	0.000323	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—IDH1—brain cancer	1.08e-05	0.000316	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—HES1—brain cancer	1.07e-05	0.000314	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ENO2—brain cancer	1.06e-05	0.000313	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—PIK3CG—brain cancer	1.06e-05	0.000312	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PIK3CG—brain cancer	1.06e-05	0.000311	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—APC—brain cancer	1.06e-05	0.000311	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—PIK3CG—brain cancer	1.04e-05	0.000306	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NOTCH2—brain cancer	1.04e-05	0.000305	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—IL2—brain cancer	1.03e-05	0.000304	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PDGFRA—brain cancer	1.02e-05	0.000299	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—PIK3CG—brain cancer	1.02e-05	0.000299	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NOTCH2—brain cancer	1.01e-05	0.000298	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—IDH1—brain cancer	1.01e-05	0.000298	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—BSG—brain cancer	9.99e-06	0.000294	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NOTCH2—brain cancer	9.92e-06	0.000292	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—VAV1—brain cancer	9.88e-06	0.000291	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—SPP1—brain cancer	9.87e-06	0.00029	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—VAV1—brain cancer	9.67e-06	0.000284	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—EGFR—brain cancer	9.63e-06	0.000283	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	9.48e-06	0.000279	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—VAV1—brain cancer	9.45e-06	0.000278	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—IL2—brain cancer	9.39e-06	0.000276	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP2C9—brain cancer	9.07e-06	0.000267	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.98e-06	0.000264	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IRS2—brain cancer	8.92e-06	0.000262	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ENO2—brain cancer	8.71e-06	0.000256	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—IDH1—brain cancer	8.59e-06	0.000253	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ENO2—brain cancer	8.5e-06	0.00025	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HES1—brain cancer	8.5e-06	0.00025	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HES1—brain cancer	8.31e-06	0.000245	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—RELA—brain cancer	8.26e-06	0.000243	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—IL2—brain cancer	8.23e-06	0.000242	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—ERBB2—brain cancer	8.21e-06	0.000241	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HES1—brain cancer	8.13e-06	0.000239	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PDGFRA—brain cancer	8.09e-06	0.000238	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—IL2—brain cancer	8.05e-06	0.000237	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ENO2—brain cancer	8.01e-06	0.000236	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PDGFRA—brain cancer	7.92e-06	0.000233	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—APC—brain cancer	7.88e-06	0.000232	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PIK3CG—brain cancer	7.88e-06	0.000232	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—IL2—brain cancer	7.87e-06	0.000232	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SPP1—brain cancer	7.86e-06	0.000231	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PDGFRA—brain cancer	7.74e-06	0.000228	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—BSG—brain cancer	7.71e-06	0.000227	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SPP1—brain cancer	7.69e-06	0.000226	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SPP1—brain cancer	7.52e-06	0.000221	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL2—brain cancer	7.48e-06	0.00022	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL2—brain cancer	7.44e-06	0.000219	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL2—brain cancer	7.31e-06	0.000215	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CCND1—brain cancer	7.25e-06	0.000213	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CTNNB1—brain cancer	7.18e-06	0.000211	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—EGFR—brain cancer	7.18e-06	0.000211	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PIK3CG—brain cancer	7.15e-06	0.00021	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL2—brain cancer	7.15e-06	0.00021	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PIK3CG—brain cancer	7.14e-06	0.00021	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IRS2—brain cancer	7.11e-06	0.000209	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.99e-06	0.000206	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IRS2—brain cancer	6.95e-06	0.000204	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IRS2—brain cancer	6.8e-06	0.0002	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ENO2—brain cancer	6.79e-06	0.0002	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—IDH1—brain cancer	6.63e-06	0.000195	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—VEGFA—brain cancer	6.32e-06	0.000186	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—APC—brain cancer	6.28e-06	0.000185	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CG—brain cancer	6.28e-06	0.000185	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—STAT3—brain cancer	6.26e-06	0.000184	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—RELA—brain cancer	6.16e-06	0.000181	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CG—brain cancer	6.14e-06	0.000181	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—APC—brain cancer	6.14e-06	0.000181	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—ERBB2—brain cancer	6.12e-06	0.00018	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—APC—brain cancer	6e-06	0.000177	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CG—brain cancer	6e-06	0.000177	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MYC—brain cancer	5.82e-06	0.000171	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—EGFR—brain cancer	5.72e-06	0.000168	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—EGFR—brain cancer	5.69e-06	0.000167	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—EGFR—brain cancer	5.59e-06	0.000164	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL2—brain cancer	5.54e-06	0.000163	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—EGFR—brain cancer	5.47e-06	0.000161	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CCND1—brain cancer	5.41e-06	0.000159	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CTNNB1—brain cancer	5.35e-06	0.000157	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ENO2—brain cancer	5.24e-06	0.000154	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CG—brain cancer	5.17e-06	0.000152	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—RELA—brain cancer	4.9e-06	0.000144	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CG—brain cancer	4.88e-06	0.000144	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ERBB2—brain cancer	4.87e-06	0.000143	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—RELA—brain cancer	4.8e-06	0.000141	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TP53—brain cancer	4.78e-06	0.000141	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ERBB2—brain cancer	4.77e-06	0.00014	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—VEGFA—brain cancer	4.71e-06	0.000139	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—RELA—brain cancer	4.69e-06	0.000138	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—STAT3—brain cancer	4.67e-06	0.000137	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ERBB2—brain cancer	4.66e-06	0.000137	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL2—brain cancer	4.42e-06	0.00013	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MYC—brain cancer	4.34e-06	0.000128	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL2—brain cancer	4.32e-06	0.000127	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCND1—brain cancer	4.3e-06	0.000127	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CTNNB1—brain cancer	4.26e-06	0.000125	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EGFR—brain cancer	4.24e-06	0.000125	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL2—brain cancer	4.22e-06	0.000124	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCND1—brain cancer	4.21e-06	0.000124	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CTNNB1—brain cancer	4.17e-06	0.000123	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCND1—brain cancer	4.12e-06	0.000121	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CTNNB1—brain cancer	4.08e-06	0.00012	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CG—brain cancer	4e-06	0.000118	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CG—brain cancer	3.9e-06	0.000115	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—VEGFA—brain cancer	3.75e-06	0.00011	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—STAT3—brain cancer	3.72e-06	0.000109	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CG—brain cancer	3.68e-06	0.000108	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—VEGFA—brain cancer	3.67e-06	0.000108	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—STAT3—brain cancer	3.64e-06	0.000107	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—VEGFA—brain cancer	3.59e-06	0.000106	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TP53—brain cancer	3.56e-06	0.000105	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—STAT3—brain cancer	3.55e-06	0.000105	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MYC—brain cancer	3.45e-06	0.000102	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MYC—brain cancer	3.38e-06	9.93e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EGFR—brain cancer	3.38e-06	9.93e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EGFR—brain cancer	3.3e-06	9.72e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MYC—brain cancer	3.3e-06	9.71e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EGFR—brain cancer	3.23e-06	9.5e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CG—brain cancer	3.11e-06	9.16e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TP53—brain cancer	2.84e-06	8.34e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TP53—brain cancer	2.77e-06	8.16e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TP53—brain cancer	2.71e-06	7.98e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CG—brain cancer	2.4e-06	7.07e-05	CbGpPWpGaD
